EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Salivary Fractalkine Differentiating Periodontitis from Periodontally Healthy Subjects

Omer Mohammed Harbood iD, Raghad Fadhil Abbas iD

International Journal of Dentistry · 2024-01 · 2024 (1)

DOI: 10.1155/2024/3007148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dentistry, online erschienen am 01.04.2024. Verfasst von Omer Mohammed Harbood und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, College of Dentistry, University of Baghdad, Baghdad, Iraq. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The chemokine “Fractalkine” (CX3CL1) and its corresponding receptor (CX3CR1), chemokine belonging to the CX3C family, have an essential role in developing several systemic inflammatory disorders. Accordingly, the proliferation, adhesion, and migration of inflammatory cells are all affected by it. In light of this, the present study attempts to address the following questions: (1) Is the salivary level of fractalkine and its receptor associated with periodontitis patients with different severities? (2) Is it possible to distinguish periodontitis from periodontally healthy subjects?

Methods

This study included 30 individuals who had been considered controls, having healthy periodontium, and 90 patients with varying stages of periodontitis. The patients were equally divided into three groups: those with Stage I, Stage II, and Stage III. After each subject’s saliva was collected, periodontal markers including bleeding on probing (BOP), probing pocket depth (PPD), and clinical attachment loss (CAL) were recorded. Enzyme‐linked immunosorbent assays (ELISA) were used to detect the protein levels of salivary CX3CL1 and CX3CR1.

Results

In comparison to the control group, patients with periodontitis had statistically increased salivary concentrations of CX3CL1 and CX3CR1 ( P < 0.001). Additionally, all clinical periodontal indicators (BOP, PPD, and CAL) had a strong association with salivary CX3CL1 and CX3CR1 levels. Furthermore, by using the ROC (receiver operating characteristic), both biomarkers showed a good ability to differentiate periodontitis from periodontally healthy subjects, and an excellent ability to distinguish Stage I and Stage III periodontitis from periodontally healthy subjects. The AUC for salivary CX3L1 and its receptors, CX3R, was 0.93 and 0.8, respectively, to distinguish Stage I from patients with good periodontal health. In contrast, the biomarkers’ AUC for separating individuals with Stage III periodontitis from those in healthy periodontal conditions was 1.

Conclusion

Fractalkine and its receptor are linked to periodontitis and may distinguish between periodontitis and healthy periodontal tissues, suggesting its role as a possible part of periodontal disease pathogenesis.

Autor:innen und Institutionen

  • Department of Periodontology, College of Dentistry, University of Baghdad, Baghdad, Iraq.

ORCID-Profile: Omer Mohammed Harbood, Raghad Fadhil Abbas

Zitieren

APA

Harbood, O. M., & Abbas, R. F. (2024). Salivary Fractalkine Differentiating Periodontitis from Periodontally Healthy Subjects. International Journal of Dentistry, 2024(1). https://doi.org/10.1155/2024/3007148

Vancouver

Harbood OM, Abbas RF. Salivary Fractalkine Differentiating Periodontitis from Periodontally Healthy Subjects. International Journal of Dentistry. 2024;2024(1). doi:10.1155/2024/3007148

BibTeX
@article{Harbood2024,
  author = {Harbood, Omer Mohammed and Abbas, Raghad Fadhil},
  title = {Salivary Fractalkine Differentiating Periodontitis from Periodontally Healthy Subjects},
  journal = {International Journal of Dentistry},
  year = {2024},
  volume = {2024},
  number = {1},
  doi = {10.1155/2024/3007148}
}
Kostenlos starten →